CIK: 0001351351 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $154,541 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALLERGAN PLC | 199,973 | $38,229 | 24.7% | $177.36 | — | SHS | G0177J108 |
| — | TIFFANY & CO NEW | 256,814 | $34,323 | 22.2% | $133.65 | — | COM | 886547108 |
| — | ZAYO GROUP HLDGS INC | 961,842 | $33,328 | 21.6% | $33.52 | — | COM | 98919V105 |
| — | QIAGEN NV | 603,714 | $20,406 | 13.2% | $33.80 | — | SHS NEW | N72482123 |
| — | MEDICINES CO | 189,500 | $16,096 | 10.4% | $84.94 | — | COM | 584688105 |
| — | BRISTOL MYERS SQUIBB CO | 1,738,723 | $5,234 | 3.4% | $3.01 | — | RIGHT 99/99/9999 | 110122157 |
| CVS | CVS HEALTH CORP | 25,934 | $1,927 | 1.2% | $57.82 | -0.1% | COM | 126650100 |
| — | INSTRUCTURE INC | 34,606 | $1,668 | 1.1% | $48.20 | — | COM | 45781U103 |
| HPQ | HP INC | 60,000 | $1,233 | 0.8% | $15.31 | 0.0% | COM | 40434L105 |
| — | MELLANOX TECHNOLOGIES LTD | 6,250 | $732 | 0.5% | $118.36 | — | SHS | M51363113 |
| CVS | CVS HEALTH CORP | 9,500 | $706 | 0.5% | $57.82 | -0.1% | Call | 126650100 |
| — | ALTISOURCE ASSET MGMT CORP | 53,321 | $659 | 0.4% | $68.33 | — | COM | 02153X108 |